[1]
S. B. . Dudhe and S. Ghule, “Lipid-Based Formulation of Nateglinide as a Promising Strategy for Managing Solubility Challenges in Type II Diabetes Therapy: A SMEDDS Approach”, J Neonatal Surg, vol. 14, no. 32S, pp. 369–377, Jun. 2025.